Gene:
ADH1B
alcohol dehydrogenase 1B (class I), beta polypeptide
PharmGKB contains no prescribing info for this . Contact us to report known genotype-based dosing guidelines, or if you are interested in developing guidelines.
PharmGKB has no annotated drug labels with pharmacogenomic information for this . If you know of a drug label with PGx, send us a message.
PharmGKB contains no Clinical Variants that meet the highest level of criteria.
To see more Clinical Variants with lower levels of criteria, click the button at the bottom of the table.
Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.
The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.
The table below contains information about pharmacogenomic variants on PharmGKB. Please follow the link in the "Variant" column for more information about a particular variant. Each link in the "Variant" column leads to the corresponding PharmGKB Variant Page. The Variant Page contains summary data, including PharmGKB manually curated information about variant-drug pairs based on individual PubMed publications. The PMIDs for these PubMed publications can be found on the Variant Page.
The tags in the first column of the table indicate what type of information can be found on the corresponding Variant Page on the appropriate tab.
Links in the "Drugs" column lead to PharmGKB Drug Pages.
List of all variant annotations for ADH1B
|
Variant?
(147) |
Alternate Names ? | Chemicals ? |
Alleles
?
(+ chr strand) |
Function ? |
Amino Acid?
Translation |
|
|---|---|---|---|---|---|---|
| rs1229984 | NC_000004.11:g.100239319T=, NC_000004.11:g.100239319T>C, NC_000004.12:g.99318162T=, NC_000004.12:g.99318162T>C, NG_011435.1:g.8254A=, NG_011435.1:g.8254A>G, NM_000668.5:c.143A=, NM_000668.5:c.143A>G, NM_001286650.1:c.23A=, NM_001286650.1:c.23A>G, NP_000659.2:p.His48=, NP_000659.2:p.His48Arg, NP_001273579.1:p.His8=, NP_001273579.1:p.His8Arg, XM_005262730.1:c.23A=, XM_005262730.1:c.23A>G, XP_005262787.1:p.His8=, XP_005262787.1:p.His8Arg, rs11537716, rs17028836, rs17856968, rs1789884, rs52797169, rs57624638 |
T > C
|
SNP |
H48R
|
||
| rs1229985 | NC_000004.11:g.100232878A>G, NC_000004.12:g.99311721A>G, NG_011435.1:g.14695T>C, NM_000668.5:c.829-65T>C, NM_001286650.1:c.709-65T>C, XM_005262730.1:c.709-65T>C, rs1789881 |
A > G
|
SNP | |||
| rs17033 | NC_000004.11:g.100228945T>C, NC_000004.12:g.99307788T>C, NG_011435.1:g.18628A>G, NM_000668.5:c.*52A>G, NM_001286650.1:c.*52A>G, XM_005262730.1:c.*52A>G, rs3805326, rs60655048 |
T > C
|
SNP | |||
| rs1789891 | NC_000004.11:g.100250419C>A, NC_000004.12:g.99329262C>A, rs58189473 |
C > A
|
SNP | |||
| rs2018417 | NC_000004.11:g.100235140C>A, NC_000004.12:g.99313983C>A, NG_011435.1:g.12433G>T, NM_000668.5:c.666G>T, NM_001286650.1:c.546G>T, NP_000659.2:p.Ala222=, NP_001273579.1:p.Ala182=, XM_005262730.1:c.546G>T, XP_005262787.1:p.Ala182=, rs17853136, rs60364763 |
C > A
|
SNP |
A222A
|
||
| rs2066702 | NC_000004.11:g.100229017G>A, NC_000004.12:g.99307860G>A, NG_011435.1:g.18556C>T, NM_000668.5:c.1108C>T, NM_001286650.1:c.988C>T, NP_000659.2:p.Arg370Cys, NP_001273579.1:p.Arg330Cys, XM_005262730.1:c.988C>T, XP_005262787.1:p.Arg330Cys, rs55868078, rs60479679 |
G > A
|
SNP |
R370C
|
Overview
| Alternate Names: | ADH2 |
|---|---|
| Alternate Symbols: | None |
| PharmGKB Accession Id: | PA24571 |
Details
| Cytogenetic Location: | chr4 : q23 - q23 |
|---|---|
| GP mRNA Boundary†: | chr4 : 100227527 - 100242572 |
| GP Gene Boundary†: | chr4 : 100224527 - 100252572 |
| Strand: | minus |
Visualization
UCSC has a Genome Browser that you can use to view PharmGKB annotations for this gene in context with many other sources of information.
View on UCSC BrowserADH1B, also commonly known as ADH2 or ADH beta, is a Class I alcohol dehydrogenase gene. Alcohol dehydrogenases metabolize ethanol to acetaldehyde, which is subsequently metabolized by aldehyde dehydrogenases (ALDH1A, ALDH2 genes) to acetate. This metabolism occurs primarily in the liver [Article:14693654]. The Class I alcohol dehydrogenase family is comprised of ADH1A, ADH1B and ADH1C. Collectively, the Class I ADHs are responsible for the metabolism of about 70% of ethanol in the liver at a concentration of approximately 22mM [Article:16571603]. The Class I ADHs are very similar genes; each is approximately 15 kb in size, and the resulting proteins share a 93% amino acid sequence identity [Article:11274460]. All three Class I genes are clustered on chromosome 4, specifically in the region 4q22 [Article:15099407 16571603]. This class of ADHs is inhibited by pyrazole and its derivatives [Article:15099407].
ADH1B is expressed predominantly in the liver [Article:16792560]. The Km and Vmax values for ethanol as a substrate for ADH1B vary widely depending on the allele of ADH1B, with the *1 allele displaying the lowest Km and Vmax [Article:15099407]. The ADH1B*1 protein structure has been elucidated by x-ray crystallography, and a binding site has been localized near the zinc atom. The ADH1B*1 binding site is predicted to be more restrictive than either ADH1A or ADH1C*2 [Article:11274460]. In vivo, ADH1B exists as a dimer [Article:10441588]. It can either form homodimers or heterodimers with other class 1 ADHs [Article:15099407].
ADH1B*2 and ADH1C*1 are responsible for a more rapid metabolism of alcohol than the other ADH1B and ADH1C alleles. There are conflicting studies as to whether these alleles are in linkage disequilibrium [Article:10441588]. A study of three different Taiwanese populations found the genes to be in linkage disequilibrium [Article:10090900], and LD has also been found in several Caucasian populations [Article:14693654]. However, in other studies, the effect of ADH1C*1 is independent of the ADH1B*2 allele. One study analyzing the drinking habits of Japanese men found this to be the case [Article:17285601]. Another study focusing on a population from Trinidad and Tobago also found independence between ADH1B and ADH1C [Article:17134660].
ADH1B has been studied with conflicting results in association with Fetal Alcohol Syndrome, oral cancer, esophageal cancer, colorectal cancer, testicular atrophy and breast cancer [Article:15099407]. ADH1B genotype has been linked to esophageal cancer along with ALDH2 [Article:17036331]. In another study, ADH1B genotype did not correlate with the risk of laryngeal cancer in a population of Caucasian Germans [Article:12668919]. In yet another study, no correlation was found between ADH1B or ADH1C genotype and alcoholism or liver disease in a Spanish male population [Article:15519646].
ADH1B has been thought to be secondary in importance to ALDH2 in the metabolic conversion of ethanol to acetate. However, at least two studies suggest that protection from alcoholism may affected by ADH1B independently of ALDH2 [Article:10441588 16086315].
The ADH1B*1 allele has been shown to correlate with increased risk of colorectal cancer in one study [Article:17517051]. It has also been associated with increased risk of squamous cell cancer of the head and neck (SCCHN) [Article:17489985]. In one study, the ADH1B*1 allele correlated with the risk of cerebral infarction in Japanese men [Article:15534263]. This allele is more common in alcoholics and in heavy drinkers than in moderate drinkers [Article:15099407]. It is the most prevalent allele in Caucasians, although ADH1B*2 is also found in that population. It is rarely found in Asian populations.
| Citation |
M. Whirl-Carrillo, E.M. McDonagh, J. M. Hebert, L. Gong, K. Sangkuhl, C.F. Thorn, R.B. Altman and T.E. Klein.
"Pharmacogenomics Knowledge for Personalized Medicine"
Clinical Pharmacology & Therapeutics (2012) 92(4): 414-417.
Full text
|
|---|---|
| History |
Submitted by Michelle Whirl Carrillo |
| Key Publications |
|
| Variant Summaries | rs1229984, rs2066702 |
| Drugs |
Drug (1)
|
| Diseases |
PharmGKB Curated Pathways
Pathways created internally by PharmGKB based primarily on literature evidence.
-
Abacavir Pathway, Pharmacokinetics/Pharmacodynamics
Schematic representation of abacavir metabolism and mechanism of action. The potential mechanism of an abacavir hypersensitivity reaction is also shown.
-
Celecoxib Pathway, Pharmacokinetics
Schematic representation of celecoxib metabolism in human liver cell.
-
Cyclophosphamide Pathway, Pharmacodynamics
Model non-tissue-specific cancer cell displaying genes which may be involved in the cyclophosphamide pathway.
-
Ifosfamide Pathway, Pharmacodynamics
Model non-tissue specific cancer cell displaying genes which may be involved in the ifosfamide pathway.
Publications related to ADH1B: 25
LinkOuts
- UniProtKB:
- ADH1B_HUMAN (P00325)
- Ensembl:
- ENSG00000196616
- GenAtlas:
- ADH1B
- GeneCard:
- ADH1B
- MutDB:
- ADH1B
- ALFRED:
- LO000002C




